GeneNews Limited (GeneNews) is a molecular diagnostics company. The Company is focused on the application of functional genomics to enable early diagnosis and personalized health management. The Company�s Sentinel Principle detects and stages virtually any disease or medical condition from a simple blood sample. GeneNews is applies the Sentinel Principle in areas with unmet clinical needs such as cancer, arthritis, cardiovascular disease and neurological disorders. Its ColonSentry product is used to determine an individual�s risk for colorectal cancer. During the year ended December 31, 2011, the Company announced the launch of ColonSentry in Malaysia. On February 21, 2012, the Company announced that its United States marketing partner, Enzo Clinical Labs Inc, had received clearance from the New York State Department of Health to perform, market and sell the ColonSentry test as a clinical laboratory service.